Literature DB >> 18778575

Migraine at all ages.

Marcelo E Bigal1, Richard B Lipton.   

Abstract

Although the influence of age on the prevalence of migraine is well known, the clinical characterization of migraine across the lifespan remains poorly studied. Limited evidence suggests that migraine attacks get shorter and less typical with advancing age. Similar results were found for transformed migraine at different ages. In this article, we first discuss the prevalence and clinical features of episodic migraine. We then discuss the epidemiology and profile of transformed migraine across the lifespan. Clarifying the influence of age on migraine is of importance for clinical diagnosis and treatment. It also may contain clues to evolving disease biology.

Entities:  

Mesh:

Year:  2006        PMID: 18778575     DOI: 10.1007/s11916-006-0047-6

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  25 in total

1.  Use of the ICHD-II criteria in the diagnosis of pediatric migraine.

Authors:  Andrew D Hershey; Paul Winner; Marielle A Kabbouche; Jack Gladstein; Marcy Yonker; Don Lewis; Eric Pearlman; Steven L Linder; A David Rothner; Scott W Powers
Journal:  Headache       Date:  2005 Nov-Dec       Impact factor: 5.887

2.  Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

Authors:  R B Lipton; W F Stewart; S Diamond; M L Diamond; M Reed
Journal:  Headache       Date:  2001 Jul-Aug       Impact factor: 5.887

3.  Chronic daily headache in children and adolescents.

Authors:  Natalie J Wiendels; Martine C M van der Geest; Arie Knuistingh Neven; Michel D Ferrari; Laura A E M Laan
Journal:  Headache       Date:  2005-06       Impact factor: 5.887

4.  Multicenter prospective evaluation of proposed pediatric migraine revisions to the IHS criteria. Pediatric Headache Committee of the American Association for the Study of Headache.

Authors:  P Winner; W Wasiewski; J Gladstein; S Linder
Journal:  Headache       Date:  1997-10       Impact factor: 5.887

5.  Headache syndromes amongst schoolchildren in Riyadh, Saudi Arabia.

Authors:  M Al Jumah; A Awada; S Al Azzam
Journal:  Headache       Date:  2002-04       Impact factor: 5.887

6.  Migraine headaches in adolescents: a student population-based study in Monreale.

Authors:  V Raieli; D Raimondo; R Cammalleri; R Camarda
Journal:  Cephalalgia       Date:  1995-02       Impact factor: 6.292

7.  Migraine in the elderly: a comparison with migraine in young adults.

Authors:  Kátia M Martins; Carlos A Bordini; Marcelo E Bigal; José G Speciali
Journal:  Headache       Date:  2006-02       Impact factor: 5.887

8.  Epidemiology of headache and childhood migraine in an urban general practice using Ad Hoc, Vahlquist and IHS criteria.

Authors:  M J Mortimer; J Kay; A Jaron
Journal:  Dev Med Child Neurol       Date:  1992-12       Impact factor: 5.449

9.  Symptom prevalence in the elderly. An evaluation of age, sex, disease, and medication use.

Authors:  W E Hale; L L Perkins; F E May; R G Marks; R B Stewart
Journal:  J Am Geriatr Soc       Date:  1986-05       Impact factor: 5.562

10.  Classification of pediatric migraine: proposed revisions to the IHS criteria.

Authors:  P Winner; W Martinez; L Mate; L Bello
Journal:  Headache       Date:  1995 Jul-Aug       Impact factor: 5.887

View more
  10 in total

Review 1.  Why do migraines often decrease as we age?

Authors:  Frederick G Freitag
Journal:  Curr Pain Headache Rep       Date:  2013-10

2.  Prevalence of migraine in a diverse community--electronic methods for migraine ascertainment in a large integrated health plan.

Authors:  Alice Pressman; Alice Jacobson; Roderick Eguilos; Amy Gelfand; Cynthia Huynh; Luisa Hamilton; Andrew Avins; Nandini Bakshi; Kathleen Merikangas
Journal:  Cephalalgia       Date:  2015-06-11       Impact factor: 6.292

3.  Harnessing the placebo effect in pediatric migraine clinic.

Authors:  Vanda Faria; Clas Linnman; Alyssa Lebel; David Borsook
Journal:  J Pediatr       Date:  2014-07-22       Impact factor: 4.406

Review 4.  Neurobiology of migraine progression.

Authors:  Wanakorn Rattanawong; Alan Rapoport; Anan Srikiatkhachorn
Journal:  Neurobiol Pain       Date:  2022-06-09

5.  Two young patients with stroke in conjunction with migraineus headache.

Authors:  Xue Ming; Hussam Yacoub; Anna Khanna; George C Wagner
Journal:  Open Neurol J       Date:  2010-11-15

6.  The effects of body mass index on the treatment of the patients with migraine headaches.

Authors:  Siamak Afshinmajd; Ali Davati; Farnaz Akbari
Journal:  Iran J Neurol       Date:  2011

7.  Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials.

Authors:  Virginia L Stauffer; Ira Turner; Phebe Kemmer; William Kielbasa; Kathleen Day; Martha Port; Tonya Quinlan; Angelo Camporeale
Journal:  J Headache Pain       Date:  2020-06-23       Impact factor: 7.277

Review 8.  Headache in ADHD as comorbidity and a side effect of medications: a systematic review and meta-analysis.

Authors:  Pei-Yin Pan; Ulf Jonsson; Sabriye Selin Şahpazoğlu Çakmak; Alexander Häge; Sarah Hohmann; Hjalmar Nobel Norrman; Jan K Buitelaar; Tobias Banaschewski; Samuele Cortese; David Coghill; Sven Bölte
Journal:  Psychol Med       Date:  2021-10-12       Impact factor: 7.723

9.  Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials.

Authors:  Christian Lampl; Viktoria Kraus; Katrina Lehner; Brett Loop; Mahan Chehrenama; Zofia Maczynska; Shannon Ritter; Jan Klatt; Josefin Snellman
Journal:  J Headache Pain       Date:  2022-08-18       Impact factor: 8.588

Review 10.  Diagnosis and management of migraine in ten steps.

Authors:  Anna K Eigenbrodt; Håkan Ashina; Sabrina Khan; Hans-Christoph Diener; Dimos D Mitsikostas; Alexandra J Sinclair; Patricia Pozo-Rosich; Paolo Martelletti; Anne Ducros; Michel Lantéri-Minet; Mark Braschinsky; Margarita Sanchez Del Rio; Oved Daniel; Aynur Özge; Ayten Mammadbayli; Mihails Arons; Kirill Skorobogatykh; Vladimir Romanenko; Gisela M Terwindt; Koen Paemeleire; Simona Sacco; Uwe Reuter; Christian Lampl; Henrik W Schytz; Zaza Katsarava; Timothy J Steiner; Messoud Ashina
Journal:  Nat Rev Neurol       Date:  2021-06-18       Impact factor: 42.937

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.